Comparison
Omega-3 (DHA/EPA) vs Apigenin
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Apigenin
Flavonoid found in chamomile, parsley, and celery. Popularized by Dr. Andrew Huberman for sleep and CD38 inhibition.
| Field | Omega-3 (DHA/EPA) | Apigenin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 50–100mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 400 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Apigenin are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Apigenin Flavonoid found in chamomile, parsley, and celery.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Apigenin (evidence B, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Apigenin if
Apigenin is the better fit when your goal aligns with its mechanism (Partial agonist at GABA-A receptors at the benzodiazepine binding site, producing mild anxiolytic and sleep-promoting effects without the dependence profile of pharmaceutical benzodiazepines) and the dose range (50–100mg) suits your protocol. Half-life is —h.